nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Convulsion—Thiotepa—sarcoma	0.0043	0.0043	CcSEcCtD
Doxylamine—Erythema—Mitoxantrone—sarcoma	0.00429	0.00429	CcSEcCtD
Doxylamine—Agranulocytosis—Etoposide—sarcoma	0.00426	0.00426	CcSEcCtD
Doxylamine—Anxiety—Thiotepa—sarcoma	0.00422	0.00422	CcSEcCtD
Doxylamine—Discomfort—Dactinomycin—sarcoma	0.00415	0.00415	CcSEcCtD
Doxylamine—Confusional state—Thiotepa—sarcoma	0.00409	0.00409	CcSEcCtD
Doxylamine—Urinary tract disorder—Etoposide—sarcoma	0.00405	0.00405	CcSEcCtD
Doxylamine—Agitation—Vincristine—sarcoma	0.00405	0.00405	CcSEcCtD
Doxylamine—Urethral disorder—Etoposide—sarcoma	0.00402	0.00402	CcSEcCtD
Doxylamine—Ill-defined disorder—Mitoxantrone—sarcoma	0.00398	0.00398	CcSEcCtD
Doxylamine—Nervous system disorder—Thiotepa—sarcoma	0.00398	0.00398	CcSEcCtD
Doxylamine—Thrombocytopenia—Thiotepa—sarcoma	0.00397	0.00397	CcSEcCtD
Doxylamine—Vertigo—Vincristine—sarcoma	0.00396	0.00396	CcSEcCtD
Doxylamine—Tachycardia—Thiotepa—sarcoma	0.00396	0.00396	CcSEcCtD
Doxylamine—Leukopenia—Vincristine—sarcoma	0.00394	0.00394	CcSEcCtD
Doxylamine—Thrombocytopenia—Dactinomycin—sarcoma	0.00394	0.00394	CcSEcCtD
Doxylamine—Erythema multiforme—Etoposide—sarcoma	0.00388	0.00388	CcSEcCtD
Doxylamine—Malaise—Mitoxantrone—sarcoma	0.00387	0.00387	CcSEcCtD
Doxylamine—Anorexia—Thiotepa—sarcoma	0.00387	0.00387	CcSEcCtD
Doxylamine—Leukopenia—Mitoxantrone—sarcoma	0.00384	0.00384	CcSEcCtD
Doxylamine—Anorexia—Dactinomycin—sarcoma	0.00384	0.00384	CcSEcCtD
Doxylamine—Eye disorder—Etoposide—sarcoma	0.00383	0.00383	CcSEcCtD
Doxylamine—Convulsion—Vincristine—sarcoma	0.00382	0.00382	CcSEcCtD
Doxylamine—Cardiac disorder—Etoposide—sarcoma	0.0038	0.0038	CcSEcCtD
Doxylamine—Flushing—Etoposide—sarcoma	0.0038	0.0038	CcSEcCtD
Doxylamine—Convulsion—Mitoxantrone—sarcoma	0.00372	0.00372	CcSEcCtD
Doxylamine—Immune system disorder—Etoposide—sarcoma	0.0037	0.0037	CcSEcCtD
Doxylamine—Mediastinal disorder—Etoposide—sarcoma	0.00369	0.00369	CcSEcCtD
Doxylamine—Anxiety—Mitoxantrone—sarcoma	0.00364	0.00364	CcSEcCtD
Doxylamine—Discomfort—Mitoxantrone—sarcoma	0.00361	0.00361	CcSEcCtD
Doxylamine—Somnolence—Thiotepa—sarcoma	0.0036	0.0036	CcSEcCtD
Doxylamine—Anaphylactic shock—Vincristine—sarcoma	0.0036	0.0036	CcSEcCtD
Doxylamine—Confusional state—Mitoxantrone—sarcoma	0.00353	0.00353	CcSEcCtD
Doxylamine—Nervous system disorder—Vincristine—sarcoma	0.00353	0.00353	CcSEcCtD
Doxylamine—Decreased appetite—Thiotepa—sarcoma	0.00352	0.00352	CcSEcCtD
Doxylamine—Thrombocytopenia—Vincristine—sarcoma	0.00352	0.00352	CcSEcCtD
Doxylamine—Anaphylactic shock—Mitoxantrone—sarcoma	0.0035	0.0035	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Thiotepa—sarcoma	0.0035	0.0035	CcSEcCtD
Doxylamine—Decreased appetite—Dactinomycin—sarcoma	0.0035	0.0035	CcSEcCtD
Doxylamine—Fatigue—Thiotepa—sarcoma	0.0035	0.0035	CcSEcCtD
Doxylamine—Hyperhidrosis—Vincristine—sarcoma	0.00348	0.00348	CcSEcCtD
Doxylamine—Fatigue—Dactinomycin—sarcoma	0.00347	0.00347	CcSEcCtD
Doxylamine—Constipation—Thiotepa—sarcoma	0.00347	0.00347	CcSEcCtD
Doxylamine—Muscle spasms—Etoposide—sarcoma	0.00343	0.00343	CcSEcCtD
Doxylamine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00343	0.00343	CcSEcCtD
Doxylamine—Anorexia—Vincristine—sarcoma	0.00343	0.00343	CcSEcCtD
Doxylamine—Tachycardia—Mitoxantrone—sarcoma	0.00342	0.00342	CcSEcCtD
Doxylamine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00339	0.00339	CcSEcCtD
Doxylamine—Hypotension—Vincristine—sarcoma	0.00336	0.00336	CcSEcCtD
Doxylamine—Feeling abnormal—Thiotepa—sarcoma	0.00334	0.00334	CcSEcCtD
Doxylamine—Anorexia—Mitoxantrone—sarcoma	0.00334	0.00334	CcSEcCtD
Doxylamine—Diplopia—Epirubicin—sarcoma	0.00332	0.00332	CcSEcCtD
Doxylamine—Feeling abnormal—Dactinomycin—sarcoma	0.00332	0.00332	CcSEcCtD
Doxylamine—Ill-defined disorder—Etoposide—sarcoma	0.00331	0.00331	CcSEcCtD
Doxylamine—Hypotension—Mitoxantrone—sarcoma	0.00327	0.00327	CcSEcCtD
Doxylamine—Affect lability—Epirubicin—sarcoma	0.00327	0.00327	CcSEcCtD
Doxylamine—Insomnia—Vincristine—sarcoma	0.00325	0.00325	CcSEcCtD
Doxylamine—Urticaria—Thiotepa—sarcoma	0.00322	0.00322	CcSEcCtD
Doxylamine—Malaise—Etoposide—sarcoma	0.00322	0.00322	CcSEcCtD
Doxylamine—Vertigo—Etoposide—sarcoma	0.00321	0.00321	CcSEcCtD
Doxylamine—Leukopenia—Etoposide—sarcoma	0.00319	0.00319	CcSEcCtD
Doxylamine—Mood swings—Epirubicin—sarcoma	0.00315	0.00315	CcSEcCtD
Doxylamine—Decreased appetite—Vincristine—sarcoma	0.00313	0.00313	CcSEcCtD
Doxylamine—Dyspnoea—Mitoxantrone—sarcoma	0.00312	0.00312	CcSEcCtD
Doxylamine—Somnolence—Mitoxantrone—sarcoma	0.00311	0.00311	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Vincristine—sarcoma	0.0031	0.0031	CcSEcCtD
Doxylamine—Fatigue—Vincristine—sarcoma	0.0031	0.0031	CcSEcCtD
Doxylamine—Convulsion—Etoposide—sarcoma	0.00309	0.00309	CcSEcCtD
Doxylamine—Dehydration—Epirubicin—sarcoma	0.00309	0.00309	CcSEcCtD
Doxylamine—Constipation—Vincristine—sarcoma	0.00307	0.00307	CcSEcCtD
Doxylamine—Diplopia—Doxorubicin—sarcoma	0.00307	0.00307	CcSEcCtD
Doxylamine—Decreased appetite—Mitoxantrone—sarcoma	0.00304	0.00304	CcSEcCtD
Doxylamine—Orthostatic hypotension—Epirubicin—sarcoma	0.00303	0.00303	CcSEcCtD
Doxylamine—Affect lability—Doxorubicin—sarcoma	0.00303	0.00303	CcSEcCtD
Doxylamine—Fatigue—Mitoxantrone—sarcoma	0.00302	0.00302	CcSEcCtD
Doxylamine—Discomfort—Etoposide—sarcoma	0.003	0.003	CcSEcCtD
Doxylamine—Breast disorder—Epirubicin—sarcoma	0.003	0.003	CcSEcCtD
Doxylamine—Constipation—Mitoxantrone—sarcoma	0.00299	0.00299	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00299	0.00299	CcSEcCtD
Doxylamine—Hypersensitivity—Thiotepa—sarcoma	0.00299	0.00299	CcSEcCtD
Doxylamine—Nasopharyngitis—Epirubicin—sarcoma	0.00297	0.00297	CcSEcCtD
Doxylamine—Hypersensitivity—Dactinomycin—sarcoma	0.00296	0.00296	CcSEcCtD
Doxylamine—Confusional state—Etoposide—sarcoma	0.00294	0.00294	CcSEcCtD
Doxylamine—Anaphylactic shock—Etoposide—sarcoma	0.00291	0.00291	CcSEcCtD
Doxylamine—Mood swings—Doxorubicin—sarcoma	0.00291	0.00291	CcSEcCtD
Doxylamine—Asthenia—Thiotepa—sarcoma	0.00291	0.00291	CcSEcCtD
Doxylamine—Asthenia—Dactinomycin—sarcoma	0.00289	0.00289	CcSEcCtD
Doxylamine—Feeling abnormal—Mitoxantrone—sarcoma	0.00289	0.00289	CcSEcCtD
Doxylamine—Pruritus—Thiotepa—sarcoma	0.00287	0.00287	CcSEcCtD
Doxylamine—Dehydration—Doxorubicin—sarcoma	0.00286	0.00286	CcSEcCtD
Doxylamine—Thrombocytopenia—Etoposide—sarcoma	0.00285	0.00285	CcSEcCtD
Doxylamine—Tachycardia—Etoposide—sarcoma	0.00284	0.00284	CcSEcCtD
Doxylamine—Hyperhidrosis—Etoposide—sarcoma	0.00282	0.00282	CcSEcCtD
Doxylamine—Pancreatitis—Epirubicin—sarcoma	0.00281	0.00281	CcSEcCtD
Doxylamine—Orthostatic hypotension—Doxorubicin—sarcoma	0.00281	0.00281	CcSEcCtD
Doxylamine—Urticaria—Mitoxantrone—sarcoma	0.00278	0.00278	CcSEcCtD
Doxylamine—Breast disorder—Doxorubicin—sarcoma	0.00278	0.00278	CcSEcCtD
Doxylamine—Anorexia—Etoposide—sarcoma	0.00278	0.00278	CcSEcCtD
Doxylamine—Diarrhoea—Thiotepa—sarcoma	0.00277	0.00277	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00277	0.00277	CcSEcCtD
Doxylamine—Diarrhoea—Dactinomycin—sarcoma	0.00275	0.00275	CcSEcCtD
Doxylamine—Nasopharyngitis—Doxorubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Doxylamine—Pancytopenia—Epirubicin—sarcoma	0.00273	0.00273	CcSEcCtD
Doxylamine—Hypotension—Etoposide—sarcoma	0.00272	0.00272	CcSEcCtD
Doxylamine—Dizziness—Thiotepa—sarcoma	0.00268	0.00268	CcSEcCtD
Doxylamine—Hypersensitivity—Vincristine—sarcoma	0.00265	0.00265	CcSEcCtD
Doxylamine—Pancreatitis—Doxorubicin—sarcoma	0.0026	0.0026	CcSEcCtD
Doxylamine—Dyspnoea—Etoposide—sarcoma	0.0026	0.0026	CcSEcCtD
Doxylamine—Somnolence—Etoposide—sarcoma	0.00259	0.00259	CcSEcCtD
Doxylamine—Hypersensitivity—Mitoxantrone—sarcoma	0.00258	0.00258	CcSEcCtD
Doxylamine—Asthenia—Vincristine—sarcoma	0.00258	0.00258	CcSEcCtD
Doxylamine—Vomiting—Thiotepa—sarcoma	0.00258	0.00258	CcSEcCtD
Doxylamine—Drowsiness—Epirubicin—sarcoma	0.00256	0.00256	CcSEcCtD
Doxylamine—Vomiting—Dactinomycin—sarcoma	0.00256	0.00256	CcSEcCtD
Doxylamine—Rash—Thiotepa—sarcoma	0.00256	0.00256	CcSEcCtD
Doxylamine—Dermatitis—Thiotepa—sarcoma	0.00255	0.00255	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00254	0.00254	CcSEcCtD
Doxylamine—Rash—Dactinomycin—sarcoma	0.00254	0.00254	CcSEcCtD
Doxylamine—Decreased appetite—Etoposide—sarcoma	0.00253	0.00253	CcSEcCtD
Doxylamine—Pancytopenia—Doxorubicin—sarcoma	0.00252	0.00252	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Etoposide—sarcoma	0.00251	0.00251	CcSEcCtD
Doxylamine—Asthenia—Mitoxantrone—sarcoma	0.00251	0.00251	CcSEcCtD
Doxylamine—Fatigue—Etoposide—sarcoma	0.00251	0.00251	CcSEcCtD
Doxylamine—Constipation—Etoposide—sarcoma	0.00249	0.00249	CcSEcCtD
Doxylamine—Diarrhoea—Vincristine—sarcoma	0.00246	0.00246	CcSEcCtD
Doxylamine—Sweating—Epirubicin—sarcoma	0.00245	0.00245	CcSEcCtD
Doxylamine—Nausea—Thiotepa—sarcoma	0.00241	0.00241	CcSEcCtD
Doxylamine—Feeling abnormal—Etoposide—sarcoma	0.0024	0.0024	CcSEcCtD
Doxylamine—Diarrhoea—Mitoxantrone—sarcoma	0.0024	0.0024	CcSEcCtD
Doxylamine—Nausea—Dactinomycin—sarcoma	0.00239	0.00239	CcSEcCtD
Doxylamine—Agranulocytosis—Epirubicin—sarcoma	0.00239	0.00239	CcSEcCtD
Doxylamine—Dizziness—Vincristine—sarcoma	0.00238	0.00238	CcSEcCtD
Doxylamine—Drowsiness—Doxorubicin—sarcoma	0.00237	0.00237	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00235	0.00235	CcSEcCtD
Doxylamine—Bradycardia—Epirubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Doxylamine—Urticaria—Etoposide—sarcoma	0.00231	0.00231	CcSEcCtD
Doxylamine—Hepatitis—Epirubicin—sarcoma	0.0023	0.0023	CcSEcCtD
Doxylamine—Vomiting—Vincristine—sarcoma	0.00229	0.00229	CcSEcCtD
Doxylamine—Sweating—Doxorubicin—sarcoma	0.00227	0.00227	CcSEcCtD
Doxylamine—Urinary tract disorder—Epirubicin—sarcoma	0.00227	0.00227	CcSEcCtD
Doxylamine—Rash—Vincristine—sarcoma	0.00227	0.00227	CcSEcCtD
Doxylamine—Dermatitis—Vincristine—sarcoma	0.00226	0.00226	CcSEcCtD
Doxylamine—Urethral disorder—Epirubicin—sarcoma	0.00225	0.00225	CcSEcCtD
Doxylamine—Vomiting—Mitoxantrone—sarcoma	0.00223	0.00223	CcSEcCtD
Doxylamine—Agranulocytosis—Doxorubicin—sarcoma	0.00221	0.00221	CcSEcCtD
Doxylamine—Rash—Mitoxantrone—sarcoma	0.00221	0.00221	CcSEcCtD
Doxylamine—Dermatitis—Mitoxantrone—sarcoma	0.00221	0.00221	CcSEcCtD
Doxylamine—Erythema multiforme—Epirubicin—sarcoma	0.00217	0.00217	CcSEcCtD
Doxylamine—Bradycardia—Doxorubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Doxylamine—Eye disorder—Epirubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Doxylamine—Hypersensitivity—Etoposide—sarcoma	0.00215	0.00215	CcSEcCtD
Doxylamine—Nausea—Vincristine—sarcoma	0.00214	0.00214	CcSEcCtD
Doxylamine—Cardiac disorder—Epirubicin—sarcoma	0.00213	0.00213	CcSEcCtD
Doxylamine—Flushing—Epirubicin—sarcoma	0.00213	0.00213	CcSEcCtD
Doxylamine—Hepatitis—Doxorubicin—sarcoma	0.00213	0.00213	CcSEcCtD
Doxylamine—Urinary tract disorder—Doxorubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Doxylamine—Asthenia—Etoposide—sarcoma	0.00209	0.00209	CcSEcCtD
Doxylamine—Urethral disorder—Doxorubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Doxylamine—Nausea—Mitoxantrone—sarcoma	0.00208	0.00208	CcSEcCtD
Doxylamine—Immune system disorder—Epirubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Doxylamine—Mediastinal disorder—Epirubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Doxylamine—Pruritus—Etoposide—sarcoma	0.00206	0.00206	CcSEcCtD
Doxylamine—Erythema multiforme—Doxorubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Doxylamine—Erythema—Epirubicin—sarcoma	0.002	0.002	CcSEcCtD
Doxylamine—Diarrhoea—Etoposide—sarcoma	0.00199	0.00199	CcSEcCtD
Doxylamine—Eye disorder—Doxorubicin—sarcoma	0.00199	0.00199	CcSEcCtD
Doxylamine—Cardiac disorder—Doxorubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Doxylamine—Flushing—Doxorubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Doxylamine—Dizziness—Etoposide—sarcoma	0.00193	0.00193	CcSEcCtD
Doxylamine—Muscle spasms—Epirubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Doxylamine—Immune system disorder—Doxorubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Doxylamine—Mediastinal disorder—Doxorubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Doxylamine—Ill-defined disorder—Epirubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Doxylamine—Vomiting—Etoposide—sarcoma	0.00185	0.00185	CcSEcCtD
Doxylamine—Erythema—Doxorubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Doxylamine—Agitation—Epirubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Doxylamine—Rash—Etoposide—sarcoma	0.00184	0.00184	CcSEcCtD
Doxylamine—Dermatitis—Etoposide—sarcoma	0.00183	0.00183	CcSEcCtD
Doxylamine—Malaise—Epirubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Doxylamine—Vertigo—Epirubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Doxylamine—Leukopenia—Epirubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Doxylamine—Muscle spasms—Doxorubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Doxylamine—Palpitations—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Doxylamine—Convulsion—Epirubicin—sarcoma	0.00173	0.00173	CcSEcCtD
Doxylamine—Nausea—Etoposide—sarcoma	0.00173	0.00173	CcSEcCtD
Doxylamine—Ill-defined disorder—Doxorubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Doxylamine—Agitation—Doxorubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Doxylamine—Anxiety—Epirubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Doxylamine—Discomfort—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Doxylamine—Malaise—Doxorubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Doxylamine—Dry mouth—Epirubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Doxylamine—Vertigo—Doxorubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Doxylamine—Leukopenia—Doxorubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Doxylamine—Confusional state—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Doxylamine—Palpitations—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Doxylamine—Anaphylactic shock—Epirubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Doxylamine—Convulsion—Doxorubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Doxylamine—Nervous system disorder—Epirubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Doxylamine—Thrombocytopenia—Epirubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Doxylamine—Tachycardia—Epirubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Doxylamine—Hyperhidrosis—Epirubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Doxylamine—Anxiety—Doxorubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Doxylamine—Discomfort—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Doxylamine—Anorexia—Epirubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Doxylamine—Dry mouth—Doxorubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Doxylamine—Hypotension—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Doxylamine—Confusional state—Doxorubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Doxylamine—Anaphylactic shock—Doxorubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Doxylamine—Nervous system disorder—Doxorubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Doxylamine—Thrombocytopenia—Doxorubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Doxylamine—Insomnia—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Doxylamine—Tachycardia—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Doxylamine—Hyperhidrosis—Doxorubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Doxylamine—Dyspnoea—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Doxylamine—Somnolence—Epirubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Doxylamine—Anorexia—Doxorubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Doxylamine—Decreased appetite—Epirubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Doxylamine—Hypotension—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Doxylamine—Fatigue—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Doxylamine—Constipation—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Doxylamine—Insomnia—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Doxylamine—Dyspnoea—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Doxylamine—Feeling abnormal—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Doxylamine—Somnolence—Doxorubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Doxylamine—Decreased appetite—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Doxylamine—Fatigue—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Doxylamine—Urticaria—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Doxylamine—Constipation—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Doxylamine—Feeling abnormal—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Doxylamine—Hypersensitivity—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Doxylamine—Urticaria—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Doxylamine—Asthenia—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Doxylamine—Pruritus—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Doxylamine—Diarrhoea—Epirubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Doxylamine—Hypersensitivity—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Doxylamine—Asthenia—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Doxylamine—Dizziness—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Doxylamine—Pruritus—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Doxylamine—Vomiting—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Doxylamine—Diarrhoea—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Doxylamine—Rash—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Doxylamine—Dermatitis—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Doxylamine—Dizziness—Doxorubicin—sarcoma	0.000999	0.000999	CcSEcCtD
Doxylamine—Nausea—Epirubicin—sarcoma	0.00097	0.00097	CcSEcCtD
Doxylamine—Vomiting—Doxorubicin—sarcoma	0.00096	0.00096	CcSEcCtD
Doxylamine—Rash—Doxorubicin—sarcoma	0.000952	0.000952	CcSEcCtD
Doxylamine—Dermatitis—Doxorubicin—sarcoma	0.000952	0.000952	CcSEcCtD
Doxylamine—Nausea—Doxorubicin—sarcoma	0.000897	0.000897	CcSEcCtD
